MENU
PTGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Protagonist Therapeutics (PTGX) Ownership - Who owns Protagonist Therapeutics?
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
7707 Gateway Boulevard
Phone
+1 510 474-0170
Employees
112
Web
https://www.protagonist-inc.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.85B
P/E Ratio
58.86
Total Cash
574.36M
Projected Growth
N/A
Total Debt
11.36M
Revenue
207.8M
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash/Share
9.27
Total Debt/Equity
N/A
Revenue/Share
3.20 USD as % of share price
Fundamentals
PTGX
Capitalization
2.85B
P/E Ratio
58.86
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash
574M
Total Cash/Share
9.27
Total Debt
11.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.20%
Revenue
208M
ROE
N/A
Book Value
689M
P/B Ratio
4.13
Cash Flow
N/A
Earnings
0.87
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
17.26
Current Revenue Per Employee
228395.16
Dividends Per Share - Security
N/A
EBITDA
30.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
8.19
Shares Held By Institutions
3.67B
Shares Outstanding - Current
62M
Total Liabilities
53.1M
Total Volume MTD
N/A
Value
-1
Gain YTD
18.705
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of disulfide-rich peptides
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
7707 Gateway Boulevard
Phone
+1 510 474-0170
Employees
112
Web
https://www.protagonist-inc.com